Showing results (1031-1040 of 1,984) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|January 5, 2016
Opicapone as an adjunct to levodopa in patients with Parkinson's disease and end-of-dose motor fluctuations: a randomised, double-blind, controlled trialJoaquim J Ferreira, Andrew Lees, José-Francisco Rocha, et al.
The Lancet. Neurology|January 23, 2016
Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trialEmily J Henderson, Stephen R Lord, Matthew A Brodie, et al.
The Lancet. Neurology|May 16, 2016
Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammationÁngel Chamorro, Ulrich Dirnagl, Xabier Urra, et al.
The Lancet. Neurology|February 16, 2016
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trialMichael D Privitera, Timothy E Welty, Barry E Gidal, et al.
The Lancet. Neurology|May 29, 2015
Freezing of gait: a practical approach to managementJorik Nonnekes, Anke H Snijders, John G Nutt, et al.
The Lancet. Neurology|January 25, 2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAli A Habib, Chongbo Zhao, Inmaculada Aban, et al.
The Lancet. Neurology|January 25, 2025
Amyotrophic lateral sclerosis caused by FUS mutations: advances with broad implicationsThomas G Moens, Sandrine Da Cruz, Manuela Neumann, et al.
The Lancet. Neurology|December 20, 2024
Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease preventionMichael Benatar, Janice Robertson, Peter Munch Andersen
The Lancet. Neurology|November 22, 2024
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trialKevin N Sheth, Gregory W Albers, Jeffrey L Saver, et al.
The Lancet. Neurology|November 22, 2024
Multiple system atrophy: advances in pathophysiology, diagnosis, and treatmentFlorian Krismer, Alessandra Fanciulli, Wassilios G Meissner, et al.
Pageof 199